GlassScriptPhysician profile
Jonathan T Gdovin
NPI 1760633051
$5,924.36
in general payments reported to CMS, 2019-2025
9 companies · $972 in 2025
The $972 reported for 2025 was more than what 89% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,520 · 2022: $1,603 · 2023: $365 · 2024: $1,465 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,642 · Travel and Lodging: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,641.86 |
| Travel and Lodging | $1,160.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,158.09 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $1,366.32 | 2024-2025 | Synovasure Alpha Defensin, Osseofit, Persona |
| Stryker Corporation | $686.74 | 2021-2024 | Mako |
| Medtronic, INC. | $531.28 | 2021-2024 | Anteralign Spinal System With Titan Nanolock Surface Technology, Magnifuse Bone Graft, Cd Horizon Spinal System |
| Spr Therapeutics, INC | $481.26 | 2024-2025 | Sprint Pns System |
| Baxter Healthcare | $448.21 | 2021-2025 | Floseal, Tisseel |
| Intrinsic Therapeutics | $184.78 | 2025 | Barricaid Acd (Annular Closure Device) |
| Vertex Pharmaceuticals Incorporated | $52.45 | 2024-2025 | |
| Orthofix Medical, INC. | $15.23 | 2025 | Cervical-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gdovin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.